These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3625263)

  • 1. Planned interim analysis and its role in cancer clinical trials.
    Geller NL
    J Clin Oncol; 1987 Sep; 5(9):1485-90. PubMed ID: 3625263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.
    Geller NL; Pocock SJ
    Biometrics; 1987 Mar; 43(1):213-23. PubMed ID: 3567306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Problems raised by interim analysis in therapeutic trials].
    Rodary C; Nougue CC
    Bull Cancer; 1982; 69(4):387-92. PubMed ID: 7150794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Termination rules in therapeutic trials. Application of sequential methods in 2 clinical trials in hematology].
    Bénichou J; Lepage E; Chastang C
    Nouv Rev Fr Hematol (1978); 1987; 29(1):87-91. PubMed ID: 3473443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General statistical design considerations of randomized clinical trials.
    Peduzzi P
    Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim analyses for randomized clinical trials: the group sequential approach.
    Pocock SJ
    Biometrics; 1982 Mar; 38(1):153-62. PubMed ID: 7082757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive group sequential test for clinical trials with changing patient population.
    Feng H; Shao J; Chow SC
    J Biopharm Stat; 2007; 17(6):1227-38. PubMed ID: 18027228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of sequential methods in randomized clinical trials with censored response criteria].
    Benichou J; Chastang C
    Rev Epidemiol Sante Publique; 1986; 34(3):196-208. PubMed ID: 3786877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials.
    Chen YH; Li C; Lan KK
    Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flexible multi-stage design for phase II oncology trials.
    Tan MT; Xiong X
    Pharm Stat; 2011; 10(4):369-73. PubMed ID: 22328328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designs for group sequential tests.
    Fleming TR; Harrington DP; O'Brien PC
    Control Clin Trials; 1984 Dec; 5(4):348-61. PubMed ID: 6518769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit.
    Lachin JM
    Clin Trials; 2009 Dec; 6(6):565-73. PubMed ID: 19933716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled clinical trials in cancer research.
    Skovlund E
    Acta Oncol; 1996; 35 Suppl 8():27-33. PubMed ID: 9073046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On choosing the number of interim analyses in clinical trials.
    McPherson K
    Stat Med; 1982; 1(1):25-36. PubMed ID: 7187080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim analyses in clinical trials.
    Emerson SS; Fleming TR
    Oncology (Williston Park); 1990 Mar; 4(3):126-33; discussion 134, 136. PubMed ID: 2144441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim analyses and early termination of clinical trials.
    Choi SC
    J Biopharm Stat; 1997 Nov; 7(4):533-43. PubMed ID: 9358327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal timing for interim analyses in clinical trials.
    Togo K; Iwasaki M
    J Biopharm Stat; 2013; 23(5):1067-80. PubMed ID: 23957516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stopping a clinical trial very early based on unplanned interim analyses: a group sequential approach.
    Emerson SS
    Biometrics; 1995 Sep; 51(3):1152-62. PubMed ID: 7548699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early termination of clinical trials with prolonged observation of individual patients: a case study.
    van Es GA; Tijssen JG; Lubsen J; van Strik R
    Stat Med; 1987 Dec; 6(8):927-37. PubMed ID: 3438618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.